GI adaptation: Lower doses allow the digestive system to adjust, reducing nausea and vomiting Triple receptor activation: Retatrutide's unique GLP-1/GIP/glucagon mechanism requires gradual introduction Safety monitoring: Assess individual response before increasing to therapeutic doses Injection site tolerance: Verify no local reactions before committing to higher doses What to Expect in the First Week During the initial retatrutide dose, you may experience: Mild appetite reduction (typically noticeable by days 2-3) Possible nausea, especially with large or fatty meals Minor injection site reaction (redness, mild swelling) Increased satiety after smaller portions Important: Don't be discouraged if you don't see significant weight loss at 2mg

For others, it is a personal experienceperhaps you are already taking thyroid medication for an underactive thyroid and have noticed new, "mystery" symptoms like heart palpitations, heat intolerance, or a sudden change in energy levels since starting a weight-loss journey
Balance feels more insecure, especially on stairs or uneven ground
Researchers are now focusing on the drugs cost-effectiveness and high success rate, and several drugs and other treatment approaches are currently in various phases of clinical trials (ClinicalTrials.gov 2024)
Heart Int